194 related articles for article (PubMed ID: 10206830)
1. Pravastatin and coronary heart disease.
Meyer FP
N Engl J Med; 1999 Apr; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
[No Abstract] [Full Text] [Related]
2. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin and coronary heart disease.
Bloom JM
N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
[No Abstract] [Full Text] [Related]
4. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
5. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses?
Watts GF
Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879
[No Abstract] [Full Text] [Related]
6. [Treatment with statins for the reduction of cardiovascular risk].
Chiariello M
Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779
[No Abstract] [Full Text] [Related]
7. [Statins and cardiovascular disease prevention: use and prospective].
Moulin P
Nephrologie; 2000; 21(7):379-80. PubMed ID: 11200617
[No Abstract] [Full Text] [Related]
8. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
Lim PO; Yee KM
Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
[No Abstract] [Full Text] [Related]
9. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
10. Long-term follow-up of the West of Scotland Coronary Prevention Study.
DeFilippis AP; Bansal S; Blumenthal RS
N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
[No Abstract] [Full Text] [Related]
11. More on PROSPER.
Wierzbicki AS; Mikhailidis DP; Reynolds TM
Lancet; 2003 Mar; 361(9363):1135-6; author reply 1136. PubMed ID: 12672344
[No Abstract] [Full Text] [Related]
12. More on PROSPER.
Baztán JJ; Hornillos M; Rodríguez-Mañas L
Lancet; 2003 Mar; 361(9363):1135; author reply 1136. PubMed ID: 12672345
[No Abstract] [Full Text] [Related]
13. Long-term follow-up of the West of Scotland Coronary Prevention Study.
Tsubokura M; Kami M
N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526
[No Abstract] [Full Text] [Related]
14. Long-term follow-up of the West of Scotland Coronary Prevention Study.
McEvoy JW; Margey R; Blake GJ
N Engl J Med; 2008 Jan; 358(2):193; author reply 194-5. PubMed ID: 18184967
[No Abstract] [Full Text] [Related]
15. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
März W
MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
[No Abstract] [Full Text] [Related]
16. Lipid-lowering therapy and risk of coronary events.
Taylor WC
JAMA; 2003 Apr 23-30; 289(16):2070; author reply 2071-2. PubMed ID: 12709462
[No Abstract] [Full Text] [Related]
17. Lipid-lowering therapy and risk of coronary events.
Blakely JA
JAMA; 2003 Apr 23-30; 289(16):2070-1; author reply 2071-2. PubMed ID: 12709461
[No Abstract] [Full Text] [Related]
18. [HMG-CoA reductase inhibitors for prevention and treatment of coronary heart disease. Effective reduction of cardiac events and mortality].
Windler E
Fortschr Med; 1996 Mar; 114(8):89-90. PubMed ID: 8647573
[No Abstract] [Full Text] [Related]
19. Lipid-lowering therapy and risk of coronary events.
Mascitelli L; Pezzetta F
JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709464
[No Abstract] [Full Text] [Related]
20. Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
Brouwers FP; Asselbergs FW; Hillege HL; de Boer RA; Gansevoort RT; van Veldhuisen DJ; van Gilst WH
Am Heart J; 2011 Jun; 161(6):1171-8. PubMed ID: 21641365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
